|
| It's the second day of October trading, and I have the perfect game plan to get us through the week — it benefits from the news bomb about Merck's new antiviral pill for COVID-19.
And it's already affecting other areas on the stock market, especially travel stocks...
October is going to be all about playing the reopening names as Merck's announcement boosts investor sentiment on our recovering economy.
But I also expect some extreme selling in technology to continue throughout this month, and for oil to make new highs.
Luckily, on Tuesday I'm releasing nine — yes, nine — new trades that I put together that should allow us to profit in October no matter what the stock market conditions become… | | |
|
|
Jeff Z | Jeff Zananiri spent over two decades on Wall Street learning how the best made consistent money in the market. | | |
|
0 Response to "The Merck Pill Bump and Why Extreme Selling Will Continue for Tech "
Post a Comment